FDA Inspection 1169440 — Robert A. Riesenberg, M.D.

Robert A. Riesenberg, M.D. — FEI 3003215856

The FDA completed an inspection of Robert A. Riesenberg, M.D. on May 3, 2022 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 3, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Atlanta, GA (United States)

Additional Details

Clinical Investigator (CI)